Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cefiderocol: A Novel Agent for the Management of Multidrug-Resistant Gram-Negative Organisms
Janet Wu, Pavithra Srinivas, Jason M. Pogue
Infectious Diseases and Therapy (2020) Vol. 9, Iss. 1, pp. 17-40
Open Access | Times Cited: 150

Showing 1-25 of 150 citing articles:

Pneumonia
Antoní Torres, Catia Cillóniz, Michael S. Niederman, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 444
Update of the treatment of nosocomial pneumonia in the ICU
Rafael Zaragoza, Pablo Vidal, Gerardo Aguilar, et al.
Critical Care (2020) Vol. 24, Iss. 1
Open Access | Times Cited: 165
Antibiotics and Bacterial Resistance—A Short Story of an Endless Arms Race
Aleksandra Baran, Aleksandra Kwiatkowska, Leszek Potocki
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5777-5777
Open Access | Times Cited: 129
Clinical data from studies involving novel antibiotics to treat multidrug-resistant Gram-negative bacterial infections
Souha S. Kanj, Matteo Bassetti, Pattarachai Kiratisin, et al.
International Journal of Antimicrobial Agents (2022) Vol. 60, Iss. 3, pp. 106633-106633
Open Access | Times Cited: 85
OXA-48-Like β-Lactamases: Global Epidemiology, Treatment Options, and Development Pipeline
Sara E. Boyd, Alison Holmes, Richard Peck, et al.
Antimicrobial Agents and Chemotherapy (2022) Vol. 66, Iss. 8
Open Access | Times Cited: 74
Resistance-proof antimicrobial drug discovery to combat global antimicrobial resistance threat
Aditya Upadhayay, Jingjing Ling, Dharm Pal, et al.
Drug Resistance Updates (2022) Vol. 66, pp. 100890-100890
Closed Access | Times Cited: 74
Design and Synthesis of Novel Antimicrobial Agents
Zeinab Breijyeh, Rafik Karaman
Antibiotics (2023) Vol. 12, Iss. 3, pp. 628-628
Open Access | Times Cited: 68
The Role of Five-Membered Heterocycles in the Molecular Structure of Antibacterial Drugs Used in Therapy
Aura Rusu, I. Moga, Livia Uncu, et al.
Pharmaceutics (2023) Vol. 15, Iss. 11, pp. 2554-2554
Open Access | Times Cited: 53
Tackling the outer membrane: facilitating compound entry into Gram-negative bacterial pathogens
Deepanshi Saxena, Rahul Maitra, Rakhi Bormon, et al.
npj Antimicrobials and Resistance (2023) Vol. 1, Iss. 1
Open Access | Times Cited: 51
Cefiderocol either in monotherapy or combination versus best available therapy in the treatment of carbapenem-resistant Acinetobacter baumannii infections: A systematic review and meta-analysis
Lorenzo Onorato, Ilaria de Luca, Caterina Monari, et al.
Journal of Infection (2024) Vol. 88, Iss. 3, pp. 106113-106113
Open Access | Times Cited: 18
Iron Acquisition Systems of Gram-negative Bacterial Pathogens Define TonB-Dependent Pathways to Novel Antibiotics
Phillip E. Klebba, Salete M. Newton, David A. Six, et al.
Chemical Reviews (2021) Vol. 121, Iss. 9, pp. 5193-5239
Open Access | Times Cited: 97
Cefiderocol-Based Combination Therapy for “Difficult-to-Treat” Gram-Negative Severe Infections: Real-Life Case Series and Future Perspectives
Davide Fiore Bavaro, Alessandra Belati, Lucia Diella, et al.
Antibiotics (2021) Vol. 10, Iss. 6, pp. 652-652
Open Access | Times Cited: 80
Emerging Co-Pathogens: New Delhi Metallo-beta-lactamase producing Enterobacterales Infections in New York City COVID-19 Patients
Priya Nori, Wendy Szymczak, Yoram A. Puius, et al.
International Journal of Antimicrobial Agents (2020) Vol. 56, Iss. 6, pp. 106179-106179
Open Access | Times Cited: 79
Hydroxamate siderophores: Natural occurrence, chemical synthesis, iron binding affinity and use as Trojan horses against pathogens
Danah Al Shaer, Othman Al Musaimi, Beatriz G. de la Torre, et al.
European Journal of Medicinal Chemistry (2020) Vol. 208, pp. 112791-112791
Open Access | Times Cited: 77
Setting the Beta-Lactam Therapeutic Range for Critically Ill Patients: Is There a Floor or Even a Ceiling?
Erin F. Barreto, Andrew Webb, Gwendolyn Pais, et al.
Critical Care Explorations (2021) Vol. 3, Iss. 6, pp. e0446-e0446
Open Access | Times Cited: 65
Fluoroquinolones Hybrid Molecules as Promising Antibacterial Agents in the Fight against Antibacterial Resistance
Ioana-Andreea Lungu, Octavia-Laura Moldovan, Victoria Biriș, et al.
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1749-1749
Open Access | Times Cited: 59
Current Promising Strategies against Antibiotic-Resistant Bacterial Infections
Jin-zhou Ye, Xinhai Chen
Antibiotics (2022) Vol. 12, Iss. 1, pp. 67-67
Open Access | Times Cited: 39
β-Lactam potentiators to re-sensitize resistant pathogens: Discovery, development, clinical use and the way forward
Lekshmi Narendrakumar, Medha Chakraborty, Shashi Kumari, et al.
Frontiers in Microbiology (2023) Vol. 13
Open Access | Times Cited: 32
Resistance in Pseudomonas aeruginosa: A Narrative Review of Antibiogram Interpretation and Emerging Treatments
F Giovagnorio, Andrea De Vito, Giordano Madeddu, et al.
Antibiotics (2023) Vol. 12, Iss. 11, pp. 1621-1621
Open Access | Times Cited: 26
Design and Synthesis of 3-Hydroxy-pyridin-4(1H)-ones–Ciprofloxacin Conjugates as Dual Antibacterial and Antibiofilm Agents against Pseudomonas aeruginosa
Yuan‐Yuan Wang, Xiaoyi Zhang, Xiaolin Zhong, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 3, pp. 2169-2193
Closed Access | Times Cited: 24
War and peace: exploring microbial defence systems as a source of new antimicrobial therapies
Paul Dyson, İbrahim M. Banat, Gerry A. Quinn
Frontiers in Pharmacology (2025) Vol. 15
Open Access | Times Cited: 1
Antibiotic Approvals in the Last Decade: Are We Keeping Up With Resistance?
Elias B. Chahine, John A. Dougherty, Krisy‐Ann Thornby, et al.
Annals of Pharmacotherapy (2021) Vol. 56, Iss. 4, pp. 441-462
Closed Access | Times Cited: 50
Cefiderocol: A New Cephalosporin Stratagem Against Multidrug-Resistant Gram-Negative Bacteria
Sharon Onguti, Mary M. Czech, Elizabeth Robilotti, et al.
Clinical Infectious Diseases (2021) Vol. 74, Iss. 7, pp. 1303-1312
Open Access | Times Cited: 47
Microcins reveal natural mechanisms of bacterial manipulation to inform therapeutic development
Jennifer K. Parker, Bryan W. Davies
Microbiology (2022) Vol. 168, Iss. 4
Open Access | Times Cited: 30
Early appropriate diagnostics and treatment of MDR Gram-negative infections
Matteo Bassetti, Souha S. Kanj, Pattarachai Kiratisin, et al.
JAC-Antimicrobial Resistance (2022) Vol. 4, Iss. 5
Open Access | Times Cited: 30
Page 1 - Next Page

Scroll to top